Literature DB >> 26524488

Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality.

Carlos H Martinez1, David M Mannino2,3, Fabian A Jaimes4, Jeffrey L Curtis1,5, MeiLan K Han1, Nadia N Hansel6, Alejandro A Diaz7.   

Abstract

RATIONALE: Understanding factors associated with undiagnosed obstructive lung disease and its impact on mortality could inform the ongoing discussions about benefits and risks of screening and case finding.
OBJECTIVES: To define factors associated with undiagnosed obstructive lung disease and its long-term mortality.
METHODS: Cross-sectional analysis of participants, aged 20 to 79 years, in two National Health and Nutritional Examination Surveys (NHANES), NHANES III (1988-1994) and NHANES 2007-2012, with longitudinal follow-up of NHANES III participants.
MEASUREMENTS AND MAIN RESULTS: We classified participants with spirometry-confirmed obstructive disease, based on the fixed ratio definition (FEV1/FVC < 0.7), as "diagnosed" (physician diagnosis of either asthma or chronic obstructive pulmonary disease), and "undiagnosed" (no recorded physician diagnosis). For the longitudinal analysis of NHANES III participants, mortality was the outcome of interest. We tested the contribution of self-reported health status and comorbidity burden (exposure) to the odds of being undiagnosed using logistic models adjusted for demographics, smoking status, and lung function. We estimated hazard ratios (HRs) for all-cause mortality for diagnosed and undiagnosed subjects participating in NHANES III who had spirometry using Cox- proportional regression analysis. Among those with spirometry-defined obstruction, 71.2% (SE, 1.8) in NHANES III and 72.0% (SE, 1.9) in NHANES 2007-2012 were undiagnosed. In multivariate models, undiagnosed obstructive disease was consistently associated in both surveys with self-reported good/excellent health status, lower comorbidity burden, higher lung function, and being of racial/ethnic minority. Among NHANES III participants (median follow up, 14.5 yr), both undiagnosed (HR, 1.23; 95% confidence interval, 1.08-1.40) and correctly diagnosed participants (HR, 1.74; 95% confidence interval, 1.45-2.09) had higher risk for all-cause mortality than participants without obstruction.
CONCLUSIONS: Undiagnosed obstructive lung disease is common among American adults and remained unchanged over 2 decades. Although undiagnosed subjects appear healthier than those with a diagnosis, their risk of death was increased compared with subjects without obstruction. These findings need to be considered when judging the implications of case-finding programs for obstructive lung disease.

Entities:  

Keywords:  asthma; chronic obstructive pulmonary disease; comorbidities; obstructive lung disease; health status

Mesh:

Year:  2015        PMID: 26524488      PMCID: PMC4722830          DOI: 10.1513/AnnalsATS.201506-388OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  26 in total

1.  Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009.

Authors:  Lara J Akinbami; Xiang Liu
Journal:  NCHS Data Brief       Date:  2011-06

2.  Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care.

Authors:  Kylie Hill; Roger S Goldstein; Gordon H Guyatt; Maria Blouin; Wan C Tan; Lori L Davis; Diane M Heels-Ansdell; Marko Erak; Pauline J Bragaglia; Itamar E Tamari; Richard Hodder; Matthew B Stanbrook
Journal:  CMAJ       Date:  2010-04-06       Impact factor: 8.262

3.  Prevalence of selected risk behaviors and chronic diseases and conditions-steps communities, United States, 2006-2007.

Authors:  Stella Cory; Ann Ussery-Hall; Shannon Griffin-Blake; Alyssa Easton; Justin Vigeant; Lina Balluz; William Garvin; Kurt Greenlund
Journal:  MMWR Surveill Summ       Date:  2010-09-24

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

Review 5.  The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature.

Authors:  Don D Sin; LieLing Wu; S F Paul Man
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

6.  Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010.

Authors:  Earl S Ford; David M Mannino; Anne G Wheaton; Wayne H Giles; Letitia Presley-Cantrell; Janet B Croft
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

7.  Economic burden prior to COPD diagnosis: a matched case-control study in the United States.

Authors:  Manabu Akazawa; Rachel Halpern; Aylin A Riedel; Richard H Stanford; Anand Dalal; Christopher M Blanchette
Journal:  Respir Med       Date:  2008-08-28       Impact factor: 3.415

8.  The direct medical costs of undiagnosed chronic obstructive pulmonary disease.

Authors:  Douglas W Mapel; Scott B Robinson; Homa B Dastani; Hemal Shah; Amy L Phillips; Eva Lydick
Journal:  Value Health       Date:  2008-01-08       Impact factor: 5.725

Review 9.  Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Kenneth Lin; Bradley Watkins; Tamara Johnson; Joy Anne Rodriguez; Mary B Barton
Journal:  Ann Intern Med       Date:  2008-03-03       Impact factor: 25.391

10.  Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation.

Authors:  S Goya Wannamethee; A Gerald Shaper; Ann Rumley; Naveed Sattar; Peter H Whincup; Mary C Thomas; Gordon D Lowe
Journal:  Diabetes Care       Date:  2010-06-02       Impact factor: 19.112

View more
  51 in total

1.  Chronic Obstructive Pulmonary Disease in America's Black Population.

Authors:  Chinedu O Ejike; Mark T Dransfield; Nadia N Hansel; Nirupama Putcha; Sarath Raju; Carlos H Martinez; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2019-08-15       Impact factor: 21.405

2.  Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort.

Authors:  Yewande E Odeyemi; O'Dene Lewis; Julius Ngwa; Kristen Dodd; Richard F Gillum; Alem Mehari
Journal:  J Natl Med Assoc       Date:  2018-07-29       Impact factor: 1.798

Review 3.  Chronic Obstructive Pulmonary Disease in Hispanics. A 9-Year Update.

Authors:  Alejandro A Díaz; Bartolomé Celli; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

4.  Reply to Londhe et al.: CAPTURE: A Screening Tool for Chronic Obstructive Pulmonary Disease or Obstructive Airway Disease?

Authors:  Fernando J Martinez; MeiLan Han; Nancy Leidy; Barry Make; David M Mannino; Stephen I Rennard; Byron M Thomashow; Barbara P Yawn
Journal:  Am J Respir Crit Care Med       Date:  2018-01-15       Impact factor: 21.405

5.  The Burden of Rural Chronic Obstructive Pulmonary Disease: Analyses from the National Health and Nutrition Examination Survey.

Authors:  Sarath Raju; Emily P Brigham; Laura M Paulin; Nirupama Putcha; Aparna Balasubramanian; Nadia N Hansel; Meredith C McCormack
Journal:  Am J Respir Crit Care Med       Date:  2020-02-15       Impact factor: 21.405

Review 6.  Improving Detection of Early Chronic Obstructive Pulmonary Disease.

Authors:  Wassim W Labaki; MeiLan K Han
Journal:  Ann Am Thorac Soc       Date:  2018-12

7.  A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease.

Authors:  Fernando J Martinez; David Mannino; Nancy Kline Leidy; Karen G Malley; Elizabeth D Bacci; R Graham Barr; Russ P Bowler; MeiLan K Han; Julia F Houfek; Barry Make; Catherine A Meldrum; Stephen Rennard; Byron Thomashow; John Walsh; Barbara P Yawn
Journal:  Am J Respir Crit Care Med       Date:  2017-03-15       Impact factor: 21.405

Review 8.  Childhood asthma is a risk factor for the development of chronic obstructive pulmonary disease.

Authors:  Michael J McGeachie
Journal:  Curr Opin Allergy Clin Immunol       Date:  2017-04

9.  Association of Symptoms of Obstructive Lung Disease and All-Cause Mortality in Older Adult Smokers.

Authors:  Maria Theresa D Opina; Barbara J Nicklas; James F Lovato; Daniel C Files; Stephen B Kritchevsky; Wendy C Moore
Journal:  J Am Geriatr Soc       Date:  2019-06-27       Impact factor: 5.562

10.  The impact of low forced vital capacity on behavior restrictions in a population with airflow obstruction.

Authors:  Noeul Kang; Sun Hye Shin; Seonhye Gu; Danbee Kang; Juhee Cho; Ho Jung Jeong; Gee Young Suh; Hyun Lee; Hye Yun Park
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.